4//SEC Filing
Consylman Gina 4
Accession 0001209191-20-057600
CIK 0001446847other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:03 PM ET
Size
6.8 KB
Accession
0001209191-20-057600
Insider Transaction Report
Form 4
Consylman Gina
Chief Accounting Officer
Transactions
- Sale
Class A Common Stock
2020-11-09$10.92/sh−825$9,009→ 270,289 total - Sale
Class A Common Stock
2020-11-09$10.92/sh−590$6,443→ 269,699 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 2, 2018.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001546358
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 4:03 PM ET
- Size
- 6.8 KB